ModerateSelective serotonin reuptake inhibitors (SSRIs)×Centrally acting muscle relaxant
Updated · Methodology
Mechanism
After oral intake, thiocolchicoside is converted in the gut into an aglycone and then conjugated with glucuronic acid into an active metabolite. Its SmPC does not mention cytochrome P450 enzymes in this pathway (Adalgur SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). Sertraline is metabolised by CYP3A4, CYP2C19 and CYP2B6, and it is a mild to moderate inhibitor of CYP2D6 (Besitran SmPC, AEMPS), so the documents describe no pharmacokinetic link between the two drugs. The two drugs share something else. Thiocolchicoside can precipitate epileptic seizures in people with epilepsy or at risk of seizures (Adalgur SmPC, AEMPS), and seizures can also occur during sertraline treatment (Besitran SmPC, AEMPS). The documents do not say whether this risk adds up when the drugs are combined.
Symptoms
The documents describe no symptoms linked to this combination. According to their SmPCs, both drugs can cause seizures (Adalgur and Besitran SmPCs, Spanish Agency of Medicines and Medical Devices, AEMPS). Rare adverse effects of thiocolchicoside include transient agitation and clouding of consciousness, diarrhoea, stomach pain, nausea and vomiting, and drowsiness is very rare (Adalgur SmPC, AEMPS). The most common adverse effects of sertraline are nausea, diarrhoea, dry mouth, insomnia, dizziness, headache, drowsiness and fatigue (Besitran SmPC, AEMPS).
Management
No document contraindicates this combination or calls for a dose change because of it (Adalgur and Besitran SmPCs, Spanish Agency of Medicines and Medical Devices, AEMPS; Zoloft label, US Food and Drug Administration, FDA). Both drugs can cause seizures, but the documents give no action for the combination (Adalgur and Besitran SmPCs, AEMPS). Sertraline is avoided in unstable epilepsy, people with controlled epilepsy are monitored carefully, and sertraline is stopped in anyone who develops seizures (Besitran SmPC, AEMPS). Sertraline is prescribed with caution in people with a seizure disorder (Zoloft label, FDA). The oral dose of thiocolchicoside is no more than 4 mg every 6 hours, that is 16 mg a day, and treatment lasts no longer than 7 consecutive days (Adalgur SmPC, AEMPS). Higher doses and longer treatment are avoided because a thiocolchicoside metabolite caused aneuploidy in preclinical studies (Adalgur SmPC, AEMPS). The Spanish thiocolchicoside product also contains paracetamol, so other medicines the person takes are checked for paracetamol (Adalgur SmPC, AEMPS).
Your whole list in one report
Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email
Add more drugsMedicine list: everything you take in one place →
Sources
- FDA: Zoloft (sertraline hydrochloride) prescribing information (2023)– FDA label, Viatris Specialty LLC, DailyMed setid fda754f6-d0f3-4dce-a17a-927d64f912f7, revised 08/2023, sections 4, 5.2 and 7.1
- AEMPS: Ficha técnica: Sertralina, Besitran 50 mg (nº registro 59717), secciones 4.4 y 4.5 (2025)– AEMPS, CIMA, nº registro 59717, revisión 08/2025, secciones 4.4 y 4.5
- AEMPS: Ficha técnica: Paracetamol/tiocolchicósido, Adalgur 500 mg/2 mg (nº registro 46534), sección 4.4 (2025)– AEMPS, CIMA, nº registro 46534 (Adalgur 500 mg/2 mg comprimidos, Teofarma), revisión 08/2025, secciones 4.2, 4.4, 4.5 y 5.2